Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

DHT may reduce inflammation caused by certain bacteria in skin cells.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Lowering testosterone speeds up wound healing in male mice.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Testosterone may slow down wound healing and increase inflammation.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Androgens help motor neurons grow by increasing neuritin.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Including androgens in hormone therapy may lower breast cancer risk.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Celtis choseniana may help treat hair loss by reducing androgen effects and boosting hair growth signals.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.